BMC Medicine BioMed Central Open Access

First Page		Document Content
Schizophrenia Atypical antipsychotics Piperazines Organochlorides Pharmacology Antipsychotic Management of schizophrenia Positive and Negative Syndrome Scale Antidepressant Psychiatry Medicine Chemistry		BMC Medicine BioMed Central Open Access Add to Reading List Source URL: www.biomedcentral.com Download Document from Source Website File Size: 328,31 KB Share Document on Facebook

	A Genome-Wide RNAi Screen in Caenorhabditis elegans Identifies the Nicotinic Acetylcholine Receptor Subunit ACR-7 as an Antipsychotic Drug Target Taixiang Saur1,2, Sarah E. DeMarco2, Angelica Ortiz3, Gregory R. Sliwoski4 DocID: 1pRZe - View Document
	CLINICAL PRACTICE GUIDELINES FORTHE MANAGEMENT OF SCHIZOPHRENIA Document prepared by : Dr. P. Kulhara, Dr. S. Chakrabarti, Department of Psychiatry, PGIMER, Chandigarh IPS GUIDELINE COMMITTEE ON SCHIZOPHRENIA : Dr. P. Ku DocID: 1pz58 - View Document
	SPECIAL SITUATIONS TREATMENT-RESISTANCE/DIFFICULTTOTREAT PATIENTS Although the introduction of antipsychotic medication was the first specific treatment proven to be efficacious, a sizeable number of individuals receivin DocID: 1pkxQ - View Document
	2003 VOLUME 5 ISSUE 1 tox pdate UPCC A DocID: 1oDmO - View Document
	R01 suicide first submission June 2011 SPECIFIC AIMS Stress and stress-response mechanisms have been extensively associated with psychiatric diagnoses (bipolar disorder, major depressive disorder, and schizophrenia) and DocID: 1ox8V - View Document